Daily insulin dose tied to cancer risk in patients with T1DM
Daily insulin dose linked to cancer risk in multivariable model, with increasing cancer incidence in low-, medium-, high-dose insulin groups
Daily insulin dose is associated with cancer risk among individuals with type 1 diabetes, according to a research letter published online 28 July in JAMA Oncology.
Wenjun Zhong, PhD, from Merck Research Labs in West Point, Pennsylvania, and Yuanjie Mao, MD, PhD, from the Diabetes Institute at Ohio University in Athens, examined the incidence of cancer among individuals with type 1 diabetes (T1DM) during a 28-year follow-up period.
